Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Bollestad

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Scandinavian Journal of Primary Health Care|May 12, 2015
A randomized controlled trial of a diagnostic algorithm for symptoms of uncomplicated cystitis at an out-of-hours serviceMarianne Bollestad, Nils Grude, Morten Lindbaek
Scandinavian Journal of Primary Health Care|September 4, 2018
Predictors of Symptom Duration and Bacteriuria in Uncomplicated Urinary Tract InfectionMarianne Bollestad, Ingvild Vik, Nils Grude, et al.
BJGP Open|December 20, 2018
Bacteriology in uncomplicated urinary tract infections in Norwegian general practice from 2001-2015Marianne Bollestad, Ingvild Vik, Nils Grude, et al.
BMC Infectious Diseases|December 18, 2014
Ibuprofen versus mecillinam for uncomplicated cystitis--a randomized controlled trial study protocolIngvild Vik, Marianne Bollestad, Nils Grude, et al.
Antibiotics (Basel, Switzerland)|May 10, 2019
Pivmecillinam for Uncomplicated Lower Urinary Tract Infections Caused by <i>Staphylococcus saprophyticus</i>-Cumulative Observational Data from Four Recent Clinical StudiesFilip Jansåker, Marianne Bollestad, Ingvild Vik, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 23, 2019
Microbial risk factors for treatment failure of pivmecillinam in community-acquired urinary tract infections caused by ESBL-producing Escherichia coliHeidi Syre, Marit Andrea Klokkhammer Hetland, Eva Bernhoff, et al.
Acta Orthopaedica|January 30, 2024
How good are surgeons at disclosing periprosthetic joint infection at the time of revision, based on pre- and intra-operative assessment? A study on 16,922 primary total hip arthroplasties reported to the Norwegian Arthroplasty RegisterOlav Lutro, Synnøve Mo, Marianne Bollestad Tjørhom, et al.
Plos Medicine|May 16, 2018
Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women-A double-blind, randomized non-inferiority trialIngvild Vik, Marianne Bollestad, Nils Grude, et al.
BMJ Open|September 2, 2020
Predicting the use of antibiotics after initial symptomatic treatment of an uncomplicated urinary tract infection: analyses performed after a randomised controlled trialIngvild Vik, Ibrahimu Mdala, Marianne Bollestad, et al.
Acta Orthopaedica|March 4, 2025
How many doses and what type of antibiotic should be used as systemic antibiotic prophylaxis in primary hip and knee arthroplasty? A register-based study on 301,204 primary total and hemi- hip and total knee arthroplasties in Norway 2005-2023Olav Lutro, Marianne Bollestad Tjørhom, Tesfaye Hordofa Leta, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Scandinavian Journal of Primary Health Care|May 12, 2015
A randomized controlled trial of a diagnostic algorithm for symptoms of uncomplicated cystitis at an out-of-hours serviceMarianne Bollestad, Nils Grude, Morten Lindbaek
Scandinavian Journal of Primary Health Care|September 4, 2018
Predictors of Symptom Duration and Bacteriuria in Uncomplicated Urinary Tract InfectionMarianne Bollestad, Ingvild Vik, Nils Grude, et al.
BJGP Open|December 20, 2018
Bacteriology in uncomplicated urinary tract infections in Norwegian general practice from 2001-2015Marianne Bollestad, Ingvild Vik, Nils Grude, et al.
BMC Infectious Diseases|December 18, 2014
Ibuprofen versus mecillinam for uncomplicated cystitis--a randomized controlled trial study protocolIngvild Vik, Marianne Bollestad, Nils Grude, et al.
Antibiotics (Basel, Switzerland)|May 10, 2019
Pivmecillinam for Uncomplicated Lower Urinary Tract Infections Caused by <i>Staphylococcus saprophyticus</i>-Cumulative Observational Data from Four Recent Clinical StudiesFilip Jansåker, Marianne Bollestad, Ingvild Vik, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|November 23, 2019
Microbial risk factors for treatment failure of pivmecillinam in community-acquired urinary tract infections caused by ESBL-producing Escherichia coliHeidi Syre, Marit Andrea Klokkhammer Hetland, Eva Bernhoff, et al.
Acta Orthopaedica|January 30, 2024
How good are surgeons at disclosing periprosthetic joint infection at the time of revision, based on pre- and intra-operative assessment? A study on 16,922 primary total hip arthroplasties reported to the Norwegian Arthroplasty RegisterOlav Lutro, Synnøve Mo, Marianne Bollestad Tjørhom, et al.
Plos Medicine|May 16, 2018
Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women-A double-blind, randomized non-inferiority trialIngvild Vik, Marianne Bollestad, Nils Grude, et al.
BMJ Open|September 2, 2020
Predicting the use of antibiotics after initial symptomatic treatment of an uncomplicated urinary tract infection: analyses performed after a randomised controlled trialIngvild Vik, Ibrahimu Mdala, Marianne Bollestad, et al.
Acta Orthopaedica|March 4, 2025
How many doses and what type of antibiotic should be used as systemic antibiotic prophylaxis in primary hip and knee arthroplasty? A register-based study on 301,204 primary total and hemi- hip and total knee arthroplasties in Norway 2005-2023Olav Lutro, Marianne Bollestad Tjørhom, Tesfaye Hordofa Leta, et al.
Pageof 2